Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer.
Kaneko A, Kobayashi N, Miura K, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Watanabe K, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T. Kaneko A, et al. Among authors: sairenji y. Thorac Cancer. 2024 Apr 11. doi: 10.1111/1759-7714.15304. Online ahead of print. Thorac Cancer. 2024. PMID: 38602166 Free article.
Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes.
Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Kudo M, Miyazawa N, Kaneko T. Kobayashi N, et al. Among authors: sairenji y. Cancers (Basel). 2023 Oct 31;15(21):5248. doi: 10.3390/cancers15215248. Cancers (Basel). 2023. PMID: 37958421 Free PMC article.
Two cases of follicular lymphoma with MYC gene abnormalities that presented with bone marrow necrosis.
Miyazawa Y, Takei H, Kobayashi N, Akashi N, Sairenji Y, Sugisaki M, Naito C, Ishikawa T, Shimizu H, Ishizaki T, Yokohama A, Tsukamoto N, Yoshida Y, Matsumura N, Takayama Y, Handa H. Miyazawa Y, et al. Among authors: sairenji y. J Clin Exp Hematop. 2022 Dec 28;62(4):208-216. doi: 10.3960/jslrt.22004. Epub 2022 Oct 20. J Clin Exp Hematop. 2022. PMID: 36261333 Free PMC article.
Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies.
Inada M, Ishikane M, Terada M, Matsunaga A, Maeda K, Tsuchiya K, Miura K, Sairenji Y, Kinoshita N, Ujiie M, Kutsuna S, Ishizaka Y, Mitsuya H, Ohmagari N. Inada M, et al. Among authors: sairenji y. J Infect Chemother. 2021 Jul;27(7):1063-1067. doi: 10.1016/j.jiac.2021.04.017. Epub 2021 Apr 24. J Infect Chemother. 2021. PMID: 33962861 Free PMC article.